RNS & Share Price
Latest News
- Holding(s) in Company
11 September 2025 - Submission of new Phase III study protocol to FDA for expanded
indication of XENOVIEW
12 August 2025 - Block Listing Six Monthly Return
24 July 2025
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts